Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

NATURE OF BUSINESS AND GOING CONCERN (Details Narrative)

v3.6.0.2
NATURE OF BUSINESS AND GOING CONCERN (Details Narrative) - USD ($)
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2014
Aug. 30, 2012
Jun. 30, 2006
Jun. 22, 2006
Related party liabilities         $ 63,000  
Issuance of common shares 89,336,000 89,036,000 89,036,000      
UMeLook [Member]            
Ownership percentage 100.00%          
Issuance of common shares       70,000,000    
Deemed price per share       $ 0.30    
Alpha Life Sciences Ltd[Member]            
Ownership percentage         100.00%  
AlphaRx Canada Limited [Member]            
Ownership percentage 100.00%          
AlphaRx International Holdings Limited [Member]            
Ownership percentage           80.00%